PMID- 33567332 OWN - NLM STAT- MEDLINE DCOM- 20220207 LR - 20220207 IS - 1878-4216 (Electronic) IS - 0278-5846 (Linking) VI - 110 DP - 2021 Aug 30 TI - Sex differences in macular thickness of the retina in patients with psychosis spectrum disorders. PG - 110280 LID - S0278-5846(21)00039-7 [pii] LID - 10.1016/j.pnpbp.2021.110280 [doi] AB - INTRODUCTION: Imaging of retinal structure in psychosis spectrum disorders (PSD) is a novel approach to studying effect of this illness class on CNS structure. Studies of optical coherence tomography (OCT) have revealed significant reductions in regarding: retinal nerve fiber layer (RNFL), macular thickness (MT), ganglion cell-inner plexiform layer (GC-IPL) and macular volume (MV). Sex differences in retinal structure in PSD have not been previously explored. METHODS: This cross-sectional pilot study included 81 participant of age matched patients and controls. There were no differences between genders regarding illness duration and antipsychotic daily dose in the patient group. SD-OCT assessed RNFL, GC-IPL, MT, MV, and optic nerve cup-to-disc (C/D) ratio. In order to assess the main effects of illness, sex, and illness x sex interaction on the retinal parameters, general linear model was performed. RESULTS: Patients demonstrated abnormalities on all OCT indices. Effects of sex were observed for central subfield MT and C/D ratio, which were lower in females. An illness x sex interaction effect was observed for the left MT, indicating greater thinning in female patients. CONCLUSION: Sex differences in OCT findings in PSD appear to be most prominent considering macular parameters. These preliminary data may have important implications for the valid interpretation of OCT findings as potential biomarkers for PSD. CI - Copyright (c) 2021 Elsevier Inc. All rights reserved. FAU - Jerotic, Stefan AU - Jerotic S AD - Clinic for Psychiatry, University Clinical Centre of Serbia, Belgrade, Serbia. Electronic address: stefan.jerotic@gmail.com. FAU - Lalovic, Nikola AU - Lalovic N AD - Clinic for Psychiatry, University Clinical Centre of Serbia, Belgrade, Serbia. FAU - Pejovic, Slobodanka AU - Pejovic S AD - Clinic for Psychiatry, University Clinical Centre of Serbia, Belgrade, Serbia; Faculty of Medicine, University of Belgrade, Belgrade, Serbia. FAU - Mihaljevic, Marina AU - Mihaljevic M AD - Clinic for Psychiatry, University Clinical Centre of Serbia, Belgrade, Serbia; Faculty of Medicine, University of Belgrade, Belgrade, Serbia. FAU - Pavlovic, Zorana AU - Pavlovic Z AD - Clinic for Psychiatry, University Clinical Centre of Serbia, Belgrade, Serbia; Faculty of Medicine, University of Belgrade, Belgrade, Serbia. FAU - Britvic, Dubravka AU - Britvic D AD - Clinic for Psychiatry, University Clinical Centre of Serbia, Belgrade, Serbia. FAU - Risimic, Dijana AU - Risimic D AD - Faculty of Medicine, University of Belgrade, Belgrade, Serbia; Clinic for Ophthalmology, University Clinical Centre of Serbia, Belgrade, Serbia. FAU - Soldatovic, Ivan AU - Soldatovic I AD - Faculty of Medicine, University of Belgrade, Belgrade, Serbia. FAU - Silverstein, Steven M AU - Silverstein SM AD - Department of Psychiatry, University of Rochester Medical Center, Rochester, NY, USA. FAU - Maric, Nadja P AU - Maric NP AD - Faculty of Medicine, University of Belgrade, Belgrade, Serbia; Institute of Mental Health, Belgrade, Serbia. LA - eng PT - Journal Article DEP - 20210207 PL - England TA - Prog Neuropsychopharmacol Biol Psychiatry JT - Progress in neuro-psychopharmacology & biological psychiatry JID - 8211617 RN - 0 (Antipsychotic Agents) SB - IM MH - Adult MH - Antipsychotic Agents/therapeutic use MH - Cross-Sectional Studies MH - Female MH - Humans MH - Male MH - Middle Aged MH - Pilot Projects MH - Psychotic Disorders/*complications/drug therapy MH - Retina/diagnostic imaging/physiopathology MH - Sex Factors MH - *Tomography, Optical Coherence OTO - NOTNLM OT - Macula OT - Optical coherence tomography OT - Psychosis spectrum disorders OT - Retina OT - Sex differences EDAT- 2021/02/11 06:00 MHDA- 2022/02/08 06:00 CRDT- 2021/02/10 20:06 PHST- 2020/11/05 00:00 [received] PHST- 2021/01/26 00:00 [revised] PHST- 2021/02/05 00:00 [accepted] PHST- 2021/02/11 06:00 [pubmed] PHST- 2022/02/08 06:00 [medline] PHST- 2021/02/10 20:06 [entrez] AID - S0278-5846(21)00039-7 [pii] AID - 10.1016/j.pnpbp.2021.110280 [doi] PST - ppublish SO - Prog Neuropsychopharmacol Biol Psychiatry. 2021 Aug 30;110:110280. doi: 10.1016/j.pnpbp.2021.110280. Epub 2021 Feb 7.